key: cord-0918285-7lgqtk0t
authors: Pitzer, Virginia E; Chitwood, Melanie; Havumaki, Joshua; Menzies, Nicolas A; Perniciaro, Stephanie; Warren, Joshua L; Weinberger, Daniel M; Cohen, Ted
title: The Impact of Changes in Diagnostic Testing Practices on Estimates of COVID-19 Transmission in the United States
date: 2021-04-08
journal: Am J Epidemiol
DOI: 10.1093/aje/kwab089
sha: 92ce02b379030cfa9d8aa745a1de3f83cd96db1c
doc_id: 918285
cord_uid: 7lgqtk0t

Estimates of the reproductive number for novel pathogens such as severe acute respiratory syndrome coronavirus 2 are essential for understanding the potential trajectory of the epidemic and the level of intervention that is needed to bring the epidemic under control. However, most methods for estimating the basic reproductive number (R(0)) and time-varying effective reproductive number (R(t)) assume that the fraction of cases detected and reported is constant through time. We explore the impact of secular changes in diagnostic testing and reporting on estimates of R(0) and R(t) using simulated data. We then compare these patterns to data on reported cases of coronavirus disease and testing practices from different states in the United States from March 4 to August 30, 2020. We find that changes in testing practices and delays in reporting can result in biased estimates of R(0) and R(t). Examination of changes in the daily number of tests conducted and the percent of patients testing positive may be helpful for identifying the potential direction of bias. Changes in diagnostic testing and reporting processes should be monitored and taken into consideration when interpreting estimates of the reproductive number of coronavirus disease.

were characterized by difficulties in delivering and administering diagnostic tests (1) . First, the real-time quantitative PCR assay developed and distributed by the US Centers for Disease

Control and Prevention suffered from performance issues (2, 3) . As a result, all initial and confirmatory testing needed to be carried out by the Centers for Disease Control and Prevention, which led to reporting delays and capacity issues early in the epidemic (4, 5) .

Initially, tests were only administered to individuals with a history of travel to certain countries or known contact with a positive case. By the time testing capacity increased, state and local health departments were faced with heavy demand for COVID-19 testing. Only individuals meeting specific criteria could receive a test, and these criteria have varied from state to state and over time.

Concurrently, mathematical modelers were analyzing data on reported COVID-19 cases in order to develop forecasts of future incidence and evaluate the potential impact of control measures, often at the behest of policymakers and public health officials. These models typically rely on estimates of the reproductive number of the virus. The basic reproductive number (R 0 ) is defined as the expected number of secondary infections produced by an infectious individual in a fully susceptible population; this can be used to derive the expected fraction of the population that will become infected in the absence of interventions and the level of control and/or immunity that is needed to eliminate the pathogen from circulation (6) . monitoring of the impact of control measures (7) (8) (9) . As control measures are implemented and immunity increases in the population, R t will decrease (6, 10) . The value of R 0 can be estimated from the growth rate of the number of cases early in the epidemic and estimates of the generation time (i.e. the time between infection of successive cases in a transmission chain) (11) , whereas instantaneous values of R t can be estimated based on the time series of case notifications and the distribution of the generation time (7-9). These methods have been shown to be robust to under-detection and underreporting, so long as the probability that a true case is detected and reported remains constant through time (7) (8) (9) 11, 12) .

Here, we use simulations to explore the potential magnitude and direction of biases introduced by changes in diagnostic testing and reporting practices similar to those occurring during the early stages of the COVID-19 epidemic in the US. We then compute preliminary estimates of R 0 and R t for different states, based on publicly available data from The COVID Tracking Project (13) , and identify where these estimates are likely to be biased. We examine changes in testing practices and trends in the percent of tests that are positive to evaluate the potential for bias.

We simulated data using a stochastic SEIR (Susceptible-Exposed-Infected-Recovered) model to explore the potential impact of changes in testing practices on estimates of R 0 and R t . We modeled a population of 1 million individuals and initialized the epidemic with 10 infectious individuals to minimize the chances of early epidemic fadeout. We assumed everyone else was

susceptible at the start of the epidemic. New infections were assumed to arise according to a

Poisson process (approximate tau-leaping method); the state transitions and rates are described in Table 1 , and model parameters are given in Table 2 . We simulated the model to day 70 using a time-step of t=0.05 days, and assumed a decrease in the transmission rate occurring on day 50, consistent with the impact of social distancing interventions.

We tracked the number of "true cases" on day d ( As our base case, we assumed that the probability of a "true case" being reported was p rep =0.1 and the ratio of tests performed to total number of true cases was n test =0.5; we assumed a mean reporting delay between onset of infectiousness and testing results of 6.6 days (14) . We then modelled scenarios in which the fraction of true cases detected and reported (as indicated by p rep ) and the testing capacity (i.e. ratio of individuals tested to true cases, n test ) either increased or decreased linearly between days 20 and 60 of the epidemic. To examine the impact of sudden changes to the probability of a true case being tested (e.g. associated with changes in testing criteria) and testing capacity (e.g. associated with a rapid expansion of supply), we also explored scenarios in which p rep and n test increased or decreased abruptly on day 40 (Table S1 ). Finally, we examined the effect of a two-fold increase or decrease in the average reporting delay.

We performed sensitivity analyses to explore the how the results varied for different magnitudes of increase in p rep and n test (Web Appendix 1). We also explored a more realistic model for the disease and observation process, in which the probability of a true case being tested and reported, as well as the associated reporting delay, depends on symptom status and disease severity, and testing capacity increases independent of the number of true cases after the initial stages of the epidemic (Web Appendix 2).

We estimated R 0 from the growth rate of the epidemic, as described by Lipsitch et al (11) :

where r is the growth rate, V is the generation interval (which is not typically observable and usually approximated by the serial interval (15)), and f is the proportion of the generation interval spent in the latent period. The growth rate (r) was determined by fitting Poisson regression models to the daily number of "true cases" (Y d ) and reported cases (C d ) on days d=21

to 40. Thus, we implicitly assumed that cases occurring over the first 20 days of the epidemic are unlikely to have been recognized. For an SEIR model, the mean generation interval is implicitly defined as the sum of the average latent period (1/) and the average infectious period (1/) (16) , and the proportion of the generation interval spent in the latent period is f=1/(V). We estimated 95% confidence intervals (CIs) for our estimate of R 0 by incorporating uncertainty in the estimated growth rate, but did not incorporate uncertainty in f or V.

We estimated R t using the approach described by Cori et al (9) , implemented using the EpiEstim software (17) . We used a daily time step and a 7-day moving window. We assumed that the generation interval was gamma distributed (i.e. parametric) with a mean of 6.5 days and standard deviation of 4.0, consistent with data from Flaxman et al (18) .

Daily data on the reported number of positive and negative tests for COVID-19 in the US and by state were downloaded from the COVID Tracking Project on August 31, 2020 (13) . The COVID

Tracking Project data come from state/district/territory public health authorities, and occasionally, from trusted news sources, official press conferences, or (rarely) social media updates from state public health authorities or governors [12] . We analyzed the data from March 4, 2020, onward, as this is the first date that negative tests for COVID-19 were consistently reported for the entire US. We also extracted information on COVID-19 testing criteria from each state health department's website during mid-March, mid-April, and mid-May. Data sources are documented in the Appendix dataset.

To estimate R 0 from data on the daily number of reported positive COVID-19 cases in the US and different states, we fitted Poisson regression models to the first three weeks of data (March 4 through March 24, 2020) to estimate the growth rate. For states that did not report any cases early on, the Poisson regression models were fitted to data beginning the first day a positive case was reported through March 24, which is approximately one week after the national "15 Days to Slow the Spread" guidelines were announced (on March 16) (19). We assumed that the mean generation interval was 6.5 days and that the average latent period was 2.9 days (18, 20, 21) . We calculated 95% CIs for the R 0 estimates based on uncertainty in the estimated growth rate, but did not account for uncertainty in the generation interval or latent period in order to highlight the differences associated with testing practices.

Estimates of the time-varying reproductive number in each state were generated using EpiEstim (9, 17) . We again used a daily time step and 7-day moving window, and assumed that the generation interval was gamma distributed with a mean of 6.5 days and standard deviation of 4.0 (18).

Analyses were implemented using MATLAB v9.3 (MathWorks, Natick, MA). Data and code are available from https://github.com/vepitzer/COVIDtestingbias.

Based on our simulations (Web Table 1 Table 2 ). The time-varying reproductive number, R t , will also be slightly over-or underestimated ( Figure 1E-L) . However, when p rep is decreasing, the bias is partially offset by the reporting delay ( Figure 1I-L) . Importantly, the magnitude of the bias decreases over time, and estimates of R t are still able to detect the impact of sustained interventions ( Based on the number of confirmed COVID-19 cases across the US through March 24, 2020

(before any observable impact of social distancing measures, Figure 3 ), and assuming a fixed serial interval of 6.5 days, we estimate that R 0 for the US is 3.24 (95% confidence interval (CI):

3.21-3.26, accounting only for uncertainty in the growth rate). Nationally, the percent of individuals testing positive for COVID-19 increased from 10-15% in early March to around 20% in late-March ( Figure 3 ). This early increase in the % pos could be due to an increase in the fraction of true cases detected and reported or a decrease in testing capacity relative to "true" Table 5 ); trends in the % pos vary by state (Figure 4) .

Estimates of R t for the US and individual states were generally high initially (R t >3) but decreased over time (Figures 3-4, Web Figure 10 ). This may be due to a low probability of detecting cases 

During the first three months of the COVID-19 epidemic in the US, testing practices varied dramatically over time and from state to state (22) . Due to the limited availability of tests early in the epidemic, most states recommended that only those with a history of travel to affected countries or known contact with a confirmed case be tested (4, 5 the denominator). Instead, we advocate for reconstructing the under-ascertained case series based on reported deaths (for which the reporting fraction is higher and less variable over time (25) ) accounting for the relevant delay distributions (26) .

It is more difficult to detect whether the time between onset of infectiousness and the reporting of test results (i.e. the reporting delay) has changed over time. Our simulations suggest that such changes could bias estimates of R 0 and R t , but would not be reflected in the percent of individuals testing positive over time. Individual-level data on the date of symptom onset, date of testing, and date of reporting are needed to resolve this potential bias. Estimates of R t are also expected to lag behind true changes in the transmission rate due to reporting delays. Simple approaches to adjusting for the reporting delay, such as shifting the time series by the mean reporting delay or subtracting a sample of the delay distribution from each observation (i.e. convolution), fail to correct for the bias (12) . Nowcasting approaches may be useful for resolving the bias by inferring the number of infections occurring on each day based on observed cases, hospitalizations and deaths, and known reporting delays (26) (27) (28) .

We used a parsimonious transmission model and observation process in order to clearly demonstrate the bias that may result from changes to testing practices over time. The total population size at time t in the model, N(t), is equal to the sum of the Susceptible (S),

Exposed (E), Infectious (I), and Recovered (R) states. The mean reporting delay decreases from 6.6 days to 3.3 days on day 40. 

Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review

CDC Diagnostic Test for COVID-19

Labs Were Contaminated, Delaying Coronavirus Testing, Officials Say

What we know about delays in coronavirus testing

The Lost Month: How a Failure to Test Blinded the U.S. to COVID-19

Infectious Diseases of Humans

Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures

Real-time estimates in early detection of SARS

A new framework and software to estimate timevarying reproduction numbers during epidemics

Factors that make an infectious disease outbreak controllable

Transmission dynamics and control of severe acute respiratory syndrome

Practical considerations for measuring the effective reproductive number

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)

Estimation in emerging epidemics: Biases and remedies

How generation intervals shape the relationship between growth rates and reproductive numbers

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Days to Slow the Spread. The White House

Temporal dynamics in viral shedding and transmissibility of COVID-19

Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study

Getting a Coronavirus Test: What is the Experience?

Interim COVID-19 Testing Guidance for Healthcare Providers. Washington State Department of Health

Excess Deaths from COVID-19 and Other Causes

Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections

Nowcasting by Bayesian Smoothing: A flexible, generalizable model for real-time epidemic tracking

Bayesian nowcasting with adjustment for delayed and incomplete reporting to estimate COVID-19 infections in the United States

Early dynamics of transmission and control of COVID-19: a mathematical modelling study

The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study

Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study